Rezvoglar KwikPen (Insulin glargine-aglr, recombinant Subcutaneous)
Generic name: Insulin Glargine-aglr, Recombinant
Drug class:
Insulin
Usage of Rezvoglar KwikPen (Insulin glargine-aglr, recombinant Subcutaneous)
Insulin glargine-aglr injection is a long-acting type of insulin that works slowly, over about 24 hours. Insulin is one of many hormones that help the body turn the food we eat into energy. This is done by using the glucose (sugar) in the blood as quick energy. Also, insulin helps us store energy that we can use later. When you have diabetes mellitus, your body cannot make enough insulin or does not use insulin properly. This causes you to have too much sugar in your blood. Like other types of insulin, insulin glargine-aglr is used to keep your blood sugar level close to normal. You may have to use insulin glargine-aglr in combination with another type of insulin or with a type of oral diabetes medicine to keep your blood sugar under control.
This medicine is available only with your doctor's prescription.
Rezvoglar KwikPen (Insulin glargine-aglr, recombinant Subcutaneous) side effects
Along with its needed effects, a medicine may cause some unwanted effects. Although not all of these side effects may occur, if they do occur they may need medical attention.
Check with your doctor immediately if any of the following side effects occur:
More common
Incidence not known
Some side effects may occur that usually do not need medical attention. These side effects may go away during treatment as your body adjusts to the medicine. Also, your health care professional may be able to tell you about ways to prevent or reduce some of these side effects. Check with your health care professional if any of the following side effects continue or are bothersome or if you have any questions about them:
More common
Other side effects not listed may also occur in some patients. If you notice any other effects, check with your healthcare professional.
Call your doctor for medical advice about side effects. You may report side effects to the FDA at 1-800-FDA-1088.
Before taking Rezvoglar KwikPen (Insulin glargine-aglr, recombinant Subcutaneous)
In deciding to use a medicine, the risks of taking the medicine must be weighed against the good it will do. This is a decision you and your doctor will make. For this medicine, the following should be considered:
Allergies
Tell your doctor if you have ever had any unusual or allergic reaction to this medicine or any other medicines. Also tell your health care professional if you have any other types of allergies, such as to foods, dyes, preservatives, or animals. For non-prescription products, read the label or package ingredients carefully.
Pediatric
Appropriate studies performed to date have not demonstrated pediatric-specific problems that would limit the usefulness of Rezvoglar™ to treat type 1 diabetes in children 6 years of age and older and to treat type 2 diabetes in children. Safety and efficacy have been established.
Geriatric
Appropriate studies performed to date have not demonstrated geriatric-specific problems that would limit the usefulness of Rezvoglar™ in the elderly. However, elderly patients are more likely to have unwanted effects (eg, heart problems, low blood sugar), which may require caution in patients receiving this medicine.
Breast Feeding
There are no adequate studies in women for determining infant risk when using this medication during breastfeeding. Weigh the potential benefits against the potential risks before taking this medication while breastfeeding.
Interactions with Medicines
Although certain medicines should not be used together at all, in other cases two different medicines may be used together even if an interaction might occur. In these cases, your doctor may want to change the dose, or other precautions may be necessary. When you are taking this medicine, it is especially important that your healthcare professional know if you are taking any of the medicines listed below. The following interactions have been selected on the basis of their potential significance and are not necessarily all-inclusive.
Using this medicine with any of the following medicines is usually not recommended, but may be required in some cases. If both medicines are prescribed together, your doctor may change the dose or how often you use one or both of the medicines.
Using this medicine with any of the following medicines may cause an increased risk of certain side effects, but using both drugs may be the best treatment for you. If both medicines are prescribed together, your doctor may change the dose or how often you use one or both of the medicines.
Interactions with Food/Tobacco/Alcohol
Certain medicines should not be used at or around the time of eating food or eating certain types of food since interactions may occur. Using alcohol or tobacco with certain medicines may also cause interactions to occur. Discuss with your healthcare professional the use of your medicine with food, alcohol, or tobacco.
Other Medical Problems
The presence of other medical problems may affect the use of this medicine. Make sure you tell your doctor if you have any other medical problems, especially:
Relate drugs
- Admelog
- Afrezza
- Apidra
- Myxredlin
- Basaglar
- Basaglar KwikPen
- Basaglar Tempo Pen
- Exubera
- Fiasp
- Humalog
- Humalog Mix
- Humalog Mix 50/50
- Humalog Mix 50/50 KwikPen
- Humalog Mix 75/25
- Humalog Mix 75/25 KwikPen
- HumuLIN 50/50
- Humulin 70/30
- HumuLIN 70/30 KwikPen
- Humulin N
- HumuLIN N KwikPen
- Humulin R
- Humulin R (Concentrated) U-500
- HumuLIN R KwikPen (Concentrated) U-500
- Insulin Aspart
- Insulin aspart and insulin aspart protamine
- Insulin aspart and insulin degludec
- Insulin aspart protamine and insulin aspart
- Insulin aspart, recombinant
- Insulin degludec
- Insulin Detemir
- Insulin glargine
- Insulin Glargine Prefilled Pen
- Insulin Glargine Solostar Pen
- Insulin glargine, recombinant
- Insulin glargine-aglr, recombinant
- Insulin glargine-yfgn, recombinant
- Insulin glulisine
- Insulin human inhaled
- Insulin human isophane (nph)
- Insulin human regular
- Insulin inhalation
- Insulin isophane
- Insulin isophane and insulin regular
- Insulin Lispro
- Insulin lispro and insulin lispro protamine
- Insulin lispro protamine and insulin lispro
- Insulin lispro-aabc
- Insulin nph and regular
- Insulin Regular
- Insulin regular, concentrated U-500
- Lantus
- Lantus SoloStar
- Lantus Solostar Pen
- Levemir
- Levemir Flexpen
- Levemir FlexTouch
- Lispro-PFC
- Lyumjev
- Lyumjev Kwikpen (Insulin lispro Intravenous, Subcutaneous)
- Lyumjev Kwikpen (Insulin lispro-aabc Intravenous, Subcutaneous)
- Novolin 70/30
- Novolin N
- Novolin R
- NovoLog
- NovoLog FlexPen
- NovoLog Mix 70/30
- NovoLog Mix 70/30 FlexPen
- NovoLog PenFill
- ReliOn/Novolin 70/30
- ReliOn/NovoLIN N
- Rezvoglar KwikPen (Insulin glargine, recombinant Subcutaneous)
- Rezvoglar KwikPen (Insulin glargine-aglr, recombinant Subcutaneous)
- Ryzodeg 70/30
- Semglee
- Semglee (Insulin glargine, recombinant Subcutaneous)
- Semglee (Insulin glargine-yfgn, recombinant Subcutaneous)
- Semglee (Prefilled Pen)
- Semglee (Vial)
- Semglee Pen (Insulin glargine, recombinant Subcutaneous)
- Semglee Pen (Insulin glargine-yfgn, recombinant Subcutaneous)
- Toujeo
- Toujeo Max SoloStar
- Tresiba FlexTouch
How to use Rezvoglar KwikPen (Insulin glargine-aglr, recombinant Subcutaneous)
A nurse or other trained health professional may give you this medicine. You may also be taught how to give your medicine at home. This medicine is given as a shot under the skin of your stomach, thigh, or upper arm.
Always check the label before use, to make sure you have the correct type of insulin. Do not change the brand, type, or concentration unless your doctor tells you to. If you use a pump or other device, make sure the insulin is made for that device.
Always double-check both the concentration (strength) of your insulin and your dose. Concentration and dose are not the same. The dose is how many units of insulin you will use. The concentration tells how many units of insulin are in each milliliter (mL), such as 100 units/mL (U-100), but this does not mean you will use 100 units at a time.
Each package of Rezvoglar™ contains a patient information sheet. Read this sheet carefully and make sure you understand:
If you use this medicine at home, you will be shown the body areas where this shot can be given. Use a different body area each time you give yourself a shot. Keep track of where you give each shot to make sure you rotate body areas. Do not use the exact same spot for each injection. This will help prevent skin problems from the injections.
Since this medicine lowers the blood glucose over 24 hours, it should be injected once daily at bedtime. It is best to use it at about the same time every day.
This medicine should be clear and colorless before you use it. Do not use it if it looks cloudy colored, or has particles in it.
Follow carefully the special meal plan your doctor gave you. This is the most important part of controlling your condition, and is necessary if the medicine is to work properly. Also, exercise regularly and test for sugar in your blood or urine as directed.
Dosing
The dose of this medicine will be different for different patients. Follow your doctor's orders or the directions on the label. The following information includes only the average doses of this medicine. If your dose is different, do not change it unless your doctor tells you to do so.
The amount of medicine that you take depends on the strength of the medicine. Also, the number of doses you take each day, the time allowed between doses, and the length of time you take the medicine depend on the medical problem for which you are using the medicine.
Storage
Keep out of the reach of children.
Do not keep outdated medicine or medicine no longer needed.
Ask your healthcare professional how you should dispose of any medicine you do not use.
Unopened medicine: Store in the refrigerator. You may store the medicine at room temperature for 28 days. Protect from light. Do not freeze.
Opened medicine: Store at room temperature, away from direct heat and light. Do not refrigerate. Throw away any opened pen after 28 days.
Throw away used needles in a hard, closed container that the needles cannot poke through. Keep this container away from children and pets.
Warnings
Never share insulin pens or cartridges with others under any circumstances. It is not safe for one pen to be used for more than one person. Sharing needles or pens can result in transmission of hepatitis viruses, HIV, or other bloodborne illnesses.
Your doctor will want to check your progress at regular visits, especially during the first few weeks you use this medicine. Blood tests may be needed to check for unwanted effects.
It is very important to follow carefully any instructions from your health care team about:
In case of emergency—There may be a time when you need emergency help for a problem caused by your diabetes. You need to be prepared for these emergencies. It is a good idea to:
Too much insulin glargine-aglr can cause hypoglycemia (low blood sugar). Low blood sugar also can occur if you use insulin glargine-aglr with another antidiabetic medicine, changes in insulin regimen (eg, insulin strength, type of insulin, injection site), delay or miss a meal or snack, exercise more than usual, or drink alcohol. Symptoms of low blood sugar must be treated before they lead to unconsciousness (passing out). Different people may feel different symptoms of low blood sugar. It is important that you learn which symptoms of low blood sugar you usually have so that you can treat it quickly.
Symptoms of low blood sugar include anxiety, behavior change similar to being drunk, blurred vision, cold sweats, confusion, difficulty in thinking, dizziness or lightheadedness, drowsiness, excessive hunger, fast heartbeat, headache, irritability or abnormal behavior, nervousness, nightmares, restless sleep, shakiness, slurred speech, and tingling in the hands, feet, lips, or tongue.
If symptoms of low blood sugar occur, eat glucose tablets or gel, corn syrup, honey, or sugar cubes, or drink fruit juice, non diet soft drink, or sugar dissolved in water to relieve the symptoms. Also, check your blood for low blood sugar. Get to a doctor or a hospital right away if the symptoms do not improve. Someone should call for emergency help immediately if severe symptoms such as convulsions (seizures) or unconsciousness occur. Have a glucagon kit available, along with a syringe and needle, and know how to use it. Members of your household also should know how to use it.
This medicine may make you dizzy or drowsy. Do not drive or do anything else that could be dangerous until you know how this medicine affects you.
Hyperglycemia (high blood sugar) may occur if you do not take enough or skip a dose of your antidiabetic medicine, changes in insulin regimen, overeat or do not follow your meal plan, have a fever or infection, or do not exercise as much as usual.
Symptoms of high blood sugar include blurred vision, drowsiness, dry mouth, flushed, dry skin, fruit-like breath odor, increased urination, ketones in the urine, loss of appetite, stomachache, nausea, or vomiting, tiredness, trouble breathing (rapid and deep), unconsciousness, and unusual thirst.
If symptoms of high blood sugar occur, check your blood sugar level and then call your doctor for instructions.
This medicine may cause serious allergic reactions, including anaphylaxis, which can be life-threatening and requires immediate medical attention. Call your doctor right away if you have a rash, itching, trouble breathing, trouble swallowing, or any swelling of your hands, face, or mouth while you are using this medicine.
This medicine may cause low levels of potassium in your blood. Do not use medicines, supplements, or salt substitutes that contain potassium unless you have discussed this with your doctor.
Using this medicine together with other diabetes medicine (eg, thiazolidinedione [TZD] medicine) may cause serious heart problems or edema (fluid retention). Check with your doctor immediately if you are rapidly gaining weight, having chest pain or discomfort, extreme tiredness or weakness, trouble breathing, uneven heartbeat, or excessive swelling of the hands, wrist, ankles, or feet.
Disclaimer
Every effort has been made to ensure that the information provided by Drugslib.com is accurate, up-to-date, and complete, but no guarantee is made to that effect. Drug information contained herein may be time sensitive. Drugslib.com information has been compiled for use by healthcare practitioners and consumers in the United States and therefore Drugslib.com does not warrant that uses outside of the United States are appropriate, unless specifically indicated otherwise. Drugslib.com's drug information does not endorse drugs, diagnose patients or recommend therapy. Drugslib.com's drug information is an informational resource designed to assist licensed healthcare practitioners in caring for their patients and/or to serve consumers viewing this service as a supplement to, and not a substitute for, the expertise, skill, knowledge and judgment of healthcare practitioners.
The absence of a warning for a given drug or drug combination in no way should be construed to indicate that the drug or drug combination is safe, effective or appropriate for any given patient. Drugslib.com does not assume any responsibility for any aspect of healthcare administered with the aid of information Drugslib.com provides. The information contained herein is not intended to cover all possible uses, directions, precautions, warnings, drug interactions, allergic reactions, or adverse effects. If you have questions about the drugs you are taking, check with your doctor, nurse or pharmacist.
Popular Keywords
- metformin obat apa
- alahan panjang
- glimepiride obat apa
- takikardia adalah
- erau ernie
- pradiabetes
- besar88
- atrofi adalah
- kutu anjing
- trakeostomi
- mayzent pi
- enbrel auto injector not working
- enbrel interactions
- lenvima life expectancy
- leqvio pi
- what is lenvima
- lenvima pi
- empagliflozin-linagliptin
- encourage foundation for enbrel
- qulipta drug interactions